Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H18O9 |
Molecular Weight | 414.3622 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2C(=O)C3=C(C(=O)C2=CC=C1)C(O)=C4C[C@](O)(C[C@H](O)C4=C3O)C(=O)CO
InChI
InChIKey=IBZGBXXTIGCACK-CWKPULSASA-N
InChI=1S/C21H18O9/c1-30-11-4-2-3-8-14(11)20(28)16-15(17(8)25)18(26)9-5-21(29,12(24)7-22)6-10(23)13(9)19(16)27/h2-4,10,22-23,26-27,29H,5-7H2,1H3/t10-,21-/m0/s1
Molecular Formula | C21H18O9 |
Molecular Weight | 414.3622 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2311221 Sources: https://www.ncbi.nlm.nih.gov/pubmed/30406253 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:16:48 GMT 2023
by
admin
on
Fri Dec 15 16:16:48 GMT 2023
|
Record UNII |
X023T6C35L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
72401
Created by
admin on Fri Dec 15 16:16:48 GMT 2023 , Edited by admin on Fri Dec 15 16:16:48 GMT 2023
|
PRIMARY | |||
|
24385-10-2
Created by
admin on Fri Dec 15 16:16:48 GMT 2023 , Edited by admin on Fri Dec 15 16:16:48 GMT 2023
|
PRIMARY | |||
|
1225758
Created by
admin on Fri Dec 15 16:16:48 GMT 2023 , Edited by admin on Fri Dec 15 16:16:48 GMT 2023
|
PRIMARY | |||
|
X023T6C35L
Created by
admin on Fri Dec 15 16:16:48 GMT 2023 , Edited by admin on Fri Dec 15 16:16:48 GMT 2023
|
PRIMARY | |||
|
DTXSID70875303
Created by
admin on Fri Dec 15 16:16:48 GMT 2023 , Edited by admin on Fri Dec 15 16:16:48 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
|
||
|
PARENT -> METABOLITE |
The mean metabolite/parent AUC ratio is about 15% for doxorubicin aglycone
|
||
|
PARENT -> METABOLITE |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |